TARSUS PHARMACEUTICALS, INC. Mentioned by Other
Announcements and disclosures made by other companies that explicitly identify this company. Each entry names the announcing company, publication date and relationship described. Includes supply, licensing, customer, property and other business relationships when disclosed. Company filings are labelled separately from newsroom announcements. Announced agreements do not prove a payment was made; absent amounts remain missing. All retained historical announcements remain available.
| Announced | Announcing company | Publication type | Relationship | What they announced | Disclosed amount | Term | Document |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |